The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Gilbert Halley E | Director | Grant(A) | 59K | — | $0 |
| Jun 17, 2026 | Ashworth Alan | Director | Grant(A) | 59K | — | $0 |
| Jun 17, 2026 | Meyers James R | Director | Grant(A) | 59K | — | $0 |
| Jun 17, 2026 | Jones Elaine V | Director | Grant(A) | 59K | — | $0 |
| Jun 17, 2026 | Su Zhen | Director | Grant(A) | 59K | — | $0 |
| Jun 17, 2026 | Young Matthew P. | Director | Grant(A) | 59K | — | $0 |
| Jun 17, 2026 | Mohindru Mani | Director | Grant(A) | 59K | — | $0 |
| Jun 15, 2026 | Ogden Christopher | Chief Financial Officer | Sell(S) | 2K | $3.05 | $5K |
| Mar 17, 2026 | Ogden Christopher | Chief Financial Officer | Sell(S) | 19K | $6.42 | $124K |
| Mar 17, 2026 | Belvin Marcia | SVP, Chief Scientific Officer | Sell(S) | 31K | $6.42 | $202K |
| Mar 17, 2026 | McCarthy Sean A. | CEO, Director | Sell(S) | 119K | $6.42 | $764K |
| Mar 17, 2026 | Chu Yu-Waye | Chief Medical Officer | Sell(S) | 21K | $6.42 | $137K |
| Feb 2, 2026 | McCarthy Sean A. | CEO, Director | Grant(A) | 210K | — | $0 |
| Feb 2, 2026 | McCarthy Sean A. | CEO, Director | Grant(A) | 980K | — | $0 |
| Feb 2, 2026 | Ogden Christopher | Chief Financial Officer | Grant(A) | 90K | — | $0 |
| Feb 2, 2026 | Ogden Christopher | Chief Financial Officer | Grant(A) | 325K | — | $0 |
| Feb 2, 2026 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 60K | — | $0 |
| Feb 2, 2026 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 250K | — | $0 |
| Feb 2, 2026 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Feb 2, 2026 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Feb 2, 2026 | Lester Rachael | Chief Business Officer | Grant(A) | 20K | — | $0 |
| Feb 2, 2026 | Lester Rachael | Chief Business Officer | Grant(A) | 50K | — | $0 |
| Feb 2, 2026 | Lester Rachael | Chief Business Officer | Grant(A) | 50K | — | $0 |
| Nov 6, 2025 | McCarthy Sean A. | CEO, Director | Sell(S) | 102K | $4.54 | $462K |
| Oct 20, 2025 | Lester Rachael | Chief Business Officer | Grant(A) | 650K | — | $0 |
| Sep 26, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 18K | — | $0 |
| Sep 26, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 36K | — | $0 |
| Sep 26, 2025 | Ogden Christopher | Chief Financial Officer | Grant(A) | 39K | — | $0 |
| Sep 26, 2025 | Ogden Christopher | Chief Financial Officer | Grant(A) | 78K | — | $0 |
| Sep 26, 2025 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| Sep 26, 2025 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 88K | — | $0 |
| Sep 26, 2025 | McCarthy Sean A. | CEO, Director | Grant(A) | 570K | — | $0 |
| Sep 26, 2025 | McCarthy Sean A. | CEO, Director | Grant(A) | 285K | — | $0 |
| Jun 16, 2025 | McCarthy Sean A. | CEO, Director | Sell(S) | 56K | $2.69 | $149K |
| Jun 16, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Sell(S) | 14K | $2.69 | $37K |
| Jun 16, 2025 | Ogden Christopher | Chief Financial Officer | Sell(S) | 11K | $2.69 | $29K |
| Jun 13, 2025 | McCarthy Sean A. | CEO, Director | Option exercise(M) | 150K | — | $0 |
| Jun 13, 2025 | McCarthy Sean A. | CEO, Director | Option exercise(M) | 150K | — | $0 |
| Jun 13, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Option exercise(M) | 38K | — | $0 |
| Jun 13, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Option exercise(M) | 38K | — | $0 |
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | Option exercise(M) | 38K | — | $0 |
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | Sell(S) | 2K | $2.95 | $5K |
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | Option exercise(M) | 38K | — | $0 |
| Jun 11, 2025 | Ashworth Alan | Director | Grant(A) | 38K | — | $0 |
| Jun 11, 2025 | Gilbert Halley E | Director | Grant(A) | 38K | — | $0 |
| Jun 11, 2025 | Jones Elaine V | Director | Grant(A) | 38K | — | $0 |
| Jun 11, 2025 | Meyers James R | Director | Grant(A) | 38K | — | $0 |
| Jun 11, 2025 | Mohindru Mani | Director | Grant(A) | 38K | — | $0 |
| Jun 11, 2025 | Young Matthew P. | Director | Grant(A) | 38K | — | $0 |
| Jun 11, 2025 | Su Zhen | Director | Grant(A) | 38K | — | $0 |
| Mar 18, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Sell(S) | 20K | $0.60 | $12K |
| Mar 18, 2025 | Rowland Lloyd A | General Counsel | Sell(S) | 10K | $0.60 | $6K |
| Mar 18, 2025 | Chu Yu-Waye | Chief Medical Officer | Sell(S) | 4K | $0.60 | $2K |
| Mar 18, 2025 | Ogden Christopher | Chief Financial Officer | Sell(S) | 9K | $0.60 | $5K |
| Mar 18, 2025 | McCarthy Sean A. | CEO, Director | Sell(S) | 38K | $0.60 | $23K |
| Feb 4, 2025 | McCarthy Sean A. | CEO, Director | Grant(A) | 195K | — | $0 |
| Feb 4, 2025 | McCarthy Sean A. | CEO, Director | Grant(A) | 180K | — | $0 |
| Feb 4, 2025 | McCarthy Sean A. | CEO, Director | Grant(A) | 800K | — | $0 |
| Feb 4, 2025 | McCarthy Sean A. | CEO, Director | Grant(A) | 390K | — | $0 |
| Feb 4, 2025 | Ogden Christopher | Chief Financial Officer | Grant(A) | 44K | — | $0 |
| Feb 4, 2025 | Ogden Christopher | Chief Financial Officer | Grant(A) | 58K | — | $0 |
| Feb 4, 2025 | Ogden Christopher | Chief Financial Officer | Grant(A) | 115K | — | $0 |
| Feb 4, 2025 | Ogden Christopher | Chief Financial Officer | Grant(A) | 225K | — | $0 |
| Feb 4, 2025 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 58K | — | $0 |
| Feb 4, 2025 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 56K | — | $0 |
| Feb 4, 2025 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 238K | — | $0 |
| Feb 4, 2025 | Chu Yu-Waye | Chief Medical Officer | Grant(A) | 115K | — | $0 |
| Feb 4, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 58K | — | $0 |
| Feb 4, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 35K | — | $0 |
| Feb 4, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Feb 4, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Grant(A) | 115K | — | $0 |
| Aug 20, 2024 | McCarthy Sean A. | CEO, Director | Sell(S) | 14K | $1.23 | $17K |
| Aug 20, 2024 | McCarthy Sean A. | CEO, Director | Option exercise(M) | 38K | — | $0 |
| Aug 20, 2024 | McCarthy Sean A. | CEO, Director | Option exercise(M) | 38K | — | $0 |
| Aug 20, 2024 | Ogden Christopher | Chief Financial Officer | Option exercise(M) | 7K | — | $0 |
| Aug 20, 2024 | Ogden Christopher | Chief Financial Officer | Sell(S) | 2K | $1.23 | $2K |
| Aug 20, 2024 | Ogden Christopher | Chief Financial Officer | Option exercise(M) | 7K | — | $0 |
| Aug 20, 2024 | Rowland Lloyd A | General Counsel | Option exercise(M) | 11K | — | $0 |
| Aug 20, 2024 | Rowland Lloyd A | General Counsel | Sell(S) | 4K | $1.23 | $5K |
| Aug 20, 2024 | Rowland Lloyd A | General Counsel | Option exercise(M) | 11K | — | $0 |
| Aug 20, 2024 | Belvin Marcia | SVP, Chief Scientific Officer | Option exercise(M) | 11K | — | $0 |
| Aug 20, 2024 | Belvin Marcia | SVP, Chief Scientific Officer | Sell(S) | 4K | $1.23 | $5K |
| Aug 20, 2024 | Belvin Marcia | SVP, Chief Scientific Officer | Option exercise(M) | 11K | — | $0 |
| Aug 20, 2024 | Landau Jeffrey B | Chief Business Officer | Option exercise(M) | 11K | — | $0 |
| Aug 20, 2024 | Landau Jeffrey B | Chief Business Officer | Sell(S) | 4K | $1.23 | $5K |
| Aug 20, 2024 | Landau Jeffrey B | Chief Business Officer | Option exercise(M) | 11K | — | $0 |
| Jun 12, 2024 | Ogden Christopher | Chief Financial Officer | Grant(A) | 18K | — | $0 |
| Jun 12, 2024 | Ogden Christopher | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| May 15, 2024 | Ashworth Alan | Director | Grant(A) | 38K | — | $0 |
| May 15, 2024 | Gilbert Halley E | Director | Grant(A) | 38K | — | $0 |
| May 15, 2024 | Jones Elaine V | Director | Grant(A) | 38K | — | $0 |
| May 15, 2024 | Meyers James R | Director | Grant(A) | 38K | — | $0 |
| May 15, 2024 | Mohindru Mani | Director | Grant(A) | 38K | — | $0 |
| May 15, 2024 | Su Zhen | Director | Grant(A) | 38K | — | $0 |
| May 15, 2024 | Young Matthew P. | Director | Grant(A) | 38K | — | $0 |
| Mar 26, 2024 | McCarthy Sean A. | CEO, Director | Option exercise(M) | 110K | $1.57 | $172K |
| Mar 26, 2024 | McCarthy Sean A. | CEO, Director | Option exercise(M) | 110K | — | $0 |
| Mar 20, 2024 | Su Zhen | Director | Grant(A) | 76K | — | $0 |
| Mar 19, 2024 | Landau Jeffrey B | Chief Business Officer | Sell(S) | 7K | $2.09 | $14K |
| Mar 19, 2024 | Belvin Marcia | SVP, Chief Scientific Officer | Sell(S) | 13K | $2.09 | $27K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).